We are thrilled to announce that Dr. Michelle E. Howard and her team have received a two-year NIH R21 Exploratory/Developmental Research Grant (Project No: 1R21CA307014-01A1) for their project titled, “Leveraging redox dysregulation to advance DIPG treatment strategies.” This crucial funding will support the lab’s ongoing mission to break through the therapeutic resistance of Diffuse Intrinsic Pontine Glioma (DIPG).

Congratulations to Dr. Howard and everyone in the lab whose hard work made this milestone achievement possible! We look forward to seeing where this research leads.